about
Hydromorphone for neuropathic pain in adultsHydromorphone for cancer painHydromorphone for neuropathic pain in adultsIntegrated Palliative Care and Oncologic Care in Non-Small-Cell Lung CancerA Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer PainTime course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapyAAPT Diagnostic Criteria for Chronic Cancer Pain ConditionsIntegrative oncology: managing cancer pain with complementary and alternative therapies.Prevalence of analgesic prescriptions among patients with cancer in Japan: an analysis of health insurance claims data.Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain.Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)Identification of capsazepine as a novel inhibitor of system xc- and cancer-induced bone pain.Association among presence of cancer pain, inadequate pain control, and psychotropic drug use.Supporting Muslim Patients During Advanced Illness.The relationship between ethnicity and the pain experience of cancer patients: a systematic review.Differences between opioids: pharmacological, experimental, clinical and economical perspectivesTherapeutic strategies for cancer treatment related peripheral neuropathies.P2X receptors: New players in cancer pain.Tapentadol prolonged release for severe chronic cancer-related pain: effectiveness, tolerability, and influence on quality of life of the patientsCancer-related neuropathic pain in out-patient oncology clinics: a European surveyCancer Pain Management and Bone Metastases: An Update for the Clinician.Behavioral and neurochemical analysis of ongoing bone cancer pain in rats.The impact of pain control on physical and psychiatric functions of cancer patients: a nation-wide survey in Taiwan.Clinical management of pain in advanced lung cancer.Symptom burden of adults with type 2 diabetes across the disease course: diabetes & aging studyA comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers.Oral health-related quality of life in complete denture wearers depending on their socio-demographic background, prosthetic-related factors and clinical condition.Exercise and nutrition interventions in advanced lung cancer: a systematic review.Patients as collaborators: using focus groups and feedback sessions to develop an interactive, web-based self-management intervention for chronic pain.Pattern of QTc prolongation in Methadone Maintenance Therapy (MMT) subjects receiving different methadone dosages: A prospective cohort study.Effect of dose escalation with single opioid, fentanyl matrix in patients not controlling cancer pain: a multicenter, prospective, observational study in Korea.Managing cancer pain at the end of life with multiple strong opioids: a population-based retrospective cohort study in primary care.MicroRNA-93-5p may participate in the formation of morphine tolerance in bone cancer pain mouse model by targeting Smad5.Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy?Intracerebroventricular opioids for intractable pain.Chronic pain in the outpatient palliative care clinic.Expectations of pain and accompanying symptoms during cancer treatment.Assessing cancer pain.Access to opioid analgesics and pain relief for patients with cancer.Cancer pain management: what's new?
P2860
Q24187550-E8B22AA5-9241-41E6-9AA7-62F5B8B48CAEQ24194872-1262D4C9-7B1D-4E4C-AD7D-DF563D195A5DQ26471921-339A4ADA-D19C-4161-B2D3-729E1511790AQ26749199-D4738F2C-A88A-4DA8-9049-9C12046863F3Q26765986-07BDB6FD-DBD6-4175-A7F3-954CFA7BDBB7Q26863511-B3233857-24AE-4CF1-B084-0EF2843E1EDCQ28079708-938D321D-3441-48EE-990D-99C06120532BQ30417297-D7F4B6E2-FBAC-4CFF-8B56-F045292FC478Q30575838-48C237DF-357B-4F9B-A8BF-B7928206EFCBQ30657653-513EB02A-D0EA-449C-B253-9C163D39995DQ31143906-1BE6A4DB-BB12-4658-8021-B0A49CF44772Q33596824-D73B84E2-5EAC-4D07-B2A1-A0ECD423E593Q33778483-3EC1D634-D85E-406E-B8BD-6837025801B4Q33792962-498378EB-2BE0-48D5-99F7-531AA2652648Q34131355-DA79A65F-3CC0-4F7C-86D5-DDBC22CC598BQ34272502-E7FAD5C4-2CA3-4C3F-820D-283C2CF7B272Q34433406-A9C7E84E-8C85-430D-8CE5-32FC60391A75Q34567944-4990FDF4-DF40-4DEC-BBC7-1A0BEB316A8EQ34783638-913AABD1-FD8A-412B-9776-C2A7DC75D70CQ35033461-CFFE5A38-F0BA-48A2-A1F8-6A959402C44EQ36036131-07752CA8-1339-4FC7-ADF1-225F3556AD19Q36083409-2754F4FD-7B51-4640-A057-51A64B363CFCQ36211853-66D295C4-4BC9-4159-BF94-60799BEA8230Q36327481-48C0F597-F935-4F97-8476-C40D5494E2DFQ36431606-B7BC1B8F-EC4E-4505-B671-5C54992F5ED0Q36878938-F394FCD7-95A9-45CF-9C52-A1F7249050D7Q36891157-A0EF8BEB-4875-4C3E-82B7-D54540DD6CE3Q37056898-78A5940D-8C37-4C57-9FDE-4B81B90D9A99Q37325568-286266E0-8871-439C-BFD1-B38A964C7735Q37382591-3AB3320C-B55D-4152-B784-6D72457587AEQ37484560-3845F1E4-4AC2-412E-A3C6-4F36D348BB37Q37520551-2313EB5E-5A00-4419-BBBF-30593C065EF9Q37588418-C8109194-F9DE-41F3-8C96-A7B2730ABBDDQ37634989-5CDB4B82-3818-4E5E-A358-C544E87C1699Q37980479-7B8F418D-0C92-46E1-B5EE-953216FBF4C7Q38007414-1AA51937-733B-48E8-AFB6-D02E49DA9F56Q38009672-090A3ABB-31A1-4487-A4F5-12571BB4E5F6Q38010084-DF51BC3A-0ED0-4B22-A425-FA18C024200EQ38074098-E25BB7BD-0A52-46B8-BB94-346E0AE84435Q38086150-F694AB78-F39C-4979-8D98-3AF90972BB3C
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Treatment of cancer pain.
@ast
Treatment of cancer pain.
@en
Treatment of cancer pain.
@nl
type
label
Treatment of cancer pain.
@ast
Treatment of cancer pain.
@en
Treatment of cancer pain.
@nl
prefLabel
Treatment of cancer pain.
@ast
Treatment of cancer pain.
@en
Treatment of cancer pain.
@nl
P1433
P1476
Treatment of cancer pain.
@en
P2093
Russell K Portenoy
P304
P356
10.1016/S0140-6736(11)60236-5
P407
P577
2011-06-01T00:00:00Z